Lv4
480 积分 2022-12-02 加入
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysis
12小时前
待确认
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
17小时前
已完结
Construction of Bispecific T-Cell Engager Radiotracer and Its Micro-PET Evaluation in Pancreatic Cancer
17天前
已完结
PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals for the localization pulmonary metastasis in a papillary thyroid tumour patient
1个月前
已完结
Primary Extraosseous Ewing Sarcoma on 18F-FDG and 68Ga-FAPI-04 PET/CT
1个月前
已完结
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
1个月前
已完结
Hemosiderotic Fibrolipomatous Tumor on FDG PET/CT
1个月前
已完结
原发性肺印戒细胞癌18F－FDG PET/CT显像1例
1个月前
已完结
177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation
1个月前
已完结
Prostate Cancer With Neuroendocrine Differentiation Recurring After Treatment With 177Lu-PSMA: A Chance for 177Lu-DOTATATE Therapy?
1个月前
已完结
皖公网安备34019202002308
